Bipolar Disorder Trial, Recruiting NCT07406945 Sponsor: Chinese University of Hong Kong Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07406945
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been referred to the participating medical center because your doctor has recommended a specific throat/esophagus procedure called POEM — this may be due to conditions such as achalasia (a swallowing disorder), a previous surgery on the esophagus that did not work well, previous balloon treatment for a swallowing problem, or a blockage where the esophagus meets the stomach
  • You are willing and able to give your consent to participate in the study

Who may not be able to join:

  • You have a medical reason that makes it unsafe for you to have a standard camera examination of the esophagus and stomach (confirm with trial site)
  • Your swallowing symptoms are considered mild, based on a specific symptom score used by doctors called the Eckardt score (confirm with trial site)
  • You have been diagnosed with Chagas disease (a parasitic infection that can affect the esophagus and heart)
  • You are not able to safely receive general anesthesia (being fully asleep during a procedure)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +852 3505 2956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 October 2026

Where this trial is recruiting

Ecuador Hong Kong

Primary endpoints

Technical Success Rate; Clinical Success Rate; [Safety] Incidence of intraoperative complications; [Safety] Incidence of postoperative complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov